SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-060996
Filing Date
2021-11-22
Accepted
2021-11-22 07:02:13
Documents
40
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea149966-6k_kamada.htm 6-K 15889
2 KAMADA' PRESS RELEASE, DATED NOVEMBER 22, 2021, TITLED "KAMADA REPORTS THIRD QUA ea149966ex99-1_kamada.htm EX-99.1 213047
3 KAMADA LTD.'S CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2021 (UNAUDI ea149966ex99-2_kamada.htm   iXBRL EX-99.2 688313
  Complete submission text file 0001213900-21-060996.txt   3126424

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kmda-20210930.xsd EX-101.SCH 38315
5 XBRL CALCULATION FILE kmda-20210930_cal.xml EX-101.CAL 43811
6 XBRL DEFINITION FILE kmda-20210930_def.xml EX-101.DEF 114348
7 XBRL LABEL FILE kmda-20210930_lab.xml EX-101.LAB 253723
8 XBRL PRESENTATION FILE kmda-20210930_pre.xml EX-101.PRE 121891
9 EXTRACTED XBRL INSTANCE DOCUMENT ea149966ex99-2_kamada_htm.xml XML 472796
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 211430136
SIC: 2834 Pharmaceutical Preparations